Company Description
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States.
The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.
It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.
The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023.
Catheter Precision, Inc. is based in Fort Mill, South Carolina.
Country | United States |
Founded | 2002 |
IPO Date | Aug 30, 2018 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 14 |
CEO | David A. Jenkins |
Contact Details
Address: 1670 Highway 160 West, Suite 205 Fort Mill, South Carolina 29708 United States | |
Phone | 973-691-2000 |
Website | catheterprecision.com |
Stock Details
Ticker Symbol | VTAK |
Exchange | NYSEAMERICAN |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001716621 |
ISIN Number | US74933X3026 |
Employer ID | 38-3661826 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
David A. Jenkins | Chief Executive Officer and Executive Chairman |
Margrit Thomassen CPA | Interim Chief Financial Officer and Secretary |
Missiaen Huck | Chief Operating Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 3, 2024 | 8-K | Current Report |
Apr 2, 2024 | 8-K | Current Report |
Apr 1, 2024 | 10-K | Annual Report |
Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Jan 25, 2024 | 8-K | Current Report |
Jan 16, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Jan 11, 2024 | 8-K | Current Report |
Jan 4, 2024 | 8-K | Current Report |
Dec 29, 2023 | 8-K | Current Report |
Dec 28, 2023 | EFFECT | Notice of Effectiveness |